Received FDA IND clearance to evaluate CDI-988 as both norovirus preventive and treatmentExpects to initiate CDI-988 Phase 1b ...
NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum ...
Despite a recent capital raise, Shelton-based antiviral drug developer NanoViricides Inc. disclosed it does not have enough cash to fund operations beyond mid-February and will need additional ...
Scientists were pleased when they learned more about how the common cold gains a foothold in the body, identifying key cellular checkpoints that are important targets of the virus.
Australian antiviral developer Island Pharmaceuticals has appointed a Washington DC-based government affairs and health ...
In this week’s edition of InnovationRx, we look at the biotech deal frenzy, Recursion’s incoming CEO, the infant formula ...
The field of traditional medicine, with its deep historical roots, offers a multitude of natural compounds with potential therapeutic benefits. Lately, ...
The search for long-COVID treatments echoes the previous struggles against HIV/AIDS. Now researchers are taking lessons from ...
Hackensack Meridian Health and Johns Hopkins University are launching a consortium with big pharma to expedite the ...
Like many viruses, the rabies virus has a relatively small genome compared to most organisms. Scientists have now revealed ...
HOUSTON – Houston might still feel like summer, but flu season isn’t waiting for temperatures to fall in line. Doctors say ...
Learn how long the flu lasts, what symptoms occur at every stage, and what you can do to feel better and lower the risk of ...